OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion

被引:262
|
作者
Zanna, Claudia [1 ]
Ghelli, Anna [1 ]
Porcelli, Anna Maria [1 ]
Karbowski, Mariusz [2 ]
Youle, Richard J. [2 ]
Schimpf, Simone [3 ]
Wissinger, Bernd [3 ]
Pinti, Marcello [4 ,5 ]
Cossarizza, Andrea [4 ,5 ]
Vidoni, Sara [1 ]
Valentino, Maria Lucia [6 ]
Rugolo, Michela [1 ]
Carelli, Valerio [6 ]
机构
[1] Univ Bologna, Dipartimento Biol Evoluz Sperimentale, I-40126 Bologna, Italy
[2] NINDS, Biochem Sect, NIH, Bethesda, MD 20892 USA
[3] Univ Eye Hosp, Mol Genet Lab, Tubingen, Germany
[4] Univ Modena, Sezione Patol Gen, Dipartimento Sci Biomed, I-41100 Modena, Italy
[5] Univ Reggio Emilia, Dipartimento Biol Evoluz Sperimentale, Reggio Emilia, Italy
[6] Univ Bologna, Dipartimento Sci Neurol, I-40126 Bologna, Italy
关键词
OPA1; DOA; oxidative phosphorylation; mitochondrial fusion; AIF;
D O I
10.1093/brain/awm335
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dominant optic atrophy ( DOA) is characterized by retinal ganglion cell degeneration leading to optic neuropathy. A subset of DOA is caused by mutations in the OPA1 gene, encoding for a dynamin-related GTPase required for mitochondrial fusion. The functional consequences of OPA1 mutations in DOA patients are still poorly understood. This study investigated the effect of five different OPA1 pathogenic mutations on the energetic efficiency and mitochondrial network dynamics of skin fibroblasts from patients. Although DOA fibroblasts maintained their ATP levels and grew in galactose medium, i.e. under forced oxidative metabolism, a significant impairment in mitochondrial ATP synthesis driven by complex I substrates was found. Furthermore, balloon-like structures in the mitochondrial reticulum were observed in galactose medium and mitochondrial fusion was completely inhibited in about 50% of DOA fibroblasts, but not in control cells. Respiratory complex assembly and the expression level of complex I subunits were similar in control and DOA fibroblasts. Co-immunoprecipitation experiments revealed that OPA1 directly interacts with subunits of complexes I, II and III, but not IV and with apoptosis inducing factor. The results disclose a novel link between OPA1, apoptosis inducing factor and the respiratory complexes that may shed some light on the pathogenic mechanism of DOA.
引用
收藏
页码:352 / 367
页数:16
相关论文
共 50 条
  • [1] OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy
    Yu-Wai-Man, Patrick
    Trenell, Michael I.
    Hollingsworth, Kieren G.
    Griffiths, Philip G.
    Chinnery, Patrick F.
    BRAIN, 2011, 134
  • [2] OPA1 mutations and mitochondrial DNA haplotypes in autosomal dominant optic atrophy
    Han, J
    Thompson-Lowrey, AJ
    Reiss, A
    Mayorov, V
    Jlia, H
    Biousse, V
    Newman, NJ
    Brown, MD
    GENETICS IN MEDICINE, 2006, 8 (04) : 217 - 225
  • [3] Dominant (Kjer's) optic atrophy associated with mutations in OPA1 gene
    Kelifova, S.
    Honzik, T.
    Tesarova, M.
    Kousal, B.
    Liskova, P.
    Havrankova, P.
    Kolarova, H.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (01) : 33 - 42
  • [4] OPA1 Mutations Associated with Dominant Optic Atrophy Influence Optic Nerve Head Size
    Barboni, Piero
    Carbonelli, Michele
    Savini, Giacomo
    Foscarini, Beatrice
    Parisi, Vincenzo
    Valentino, Maria L.
    Carta, Arturo
    De Negri, Annamaria
    Sadun, Federico
    Zeviani, Massimo
    Sadun, Alfredo A.
    Schimpf, Simone
    Wissinger, Bernd
    Carelli, Valerio
    OPHTHALMOLOGY, 2010, 117 (08) : 1547 - 1553
  • [5] Dysregulated mitophagy and mitochondrial transport in severe dominant optic atrophy due to OPA1 mutations
    Liao, C.
    Ashley, N.
    Morten, K.
    Phadwal, K.
    Williams, A.
    Fearnley, I.
    Rosser, L.
    Lowndes, J.
    Fratter, C.
    Ferguson, D.
    Vay, L.
    Quaghebeur, G.
    Macleod, L.
    Gabriel, A.
    Downes, S.
    Simon, K.
    Votruba, M.
    Poulton, J.
    NEUROMUSCULAR DISORDERS, 2012, 22 : S3 - S3
  • [6] OPA1 mutations in Finnish families with dominant optic atrophy (DOA)
    Puomila, A
    Paananen, R
    Mäntyjärvi, M
    Sankila, EM
    Somer, M
    Savontaus, ML
    Nikoskelainen, E
    Huoponen, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 580 - 580
  • [7] Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy
    Kane, Mariame Selma
    Alban, Jennifer
    Desquiret-Dumas, Valerie
    Gueguen, Naig
    Ishak, Layal
    Ferre, Marc
    Amati-Bonneau, Patrizia
    Procaccio, Vincent
    Bonneau, Dominique
    Lenaers, Guy
    Reynier, Pascal
    Chevrollier, Arnaud
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (10) : 2284 - 2297
  • [8] Novel Mutations of the OPA1 Gene in Chinese Dominant Optic Atrophy
    Yen, May-Yung
    Wang, An-Guor
    Lin, Yen-Ching
    Fann, Ming-Ji
    Hsiao, Kwang-Jen
    OPHTHALMOLOGY, 2010, 117 (02) : 392 - 396
  • [9] Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy
    Toomes, C
    Marchbank, NJ
    Mackey, DA
    Craig, JE
    Newbury-Ecob, RA
    Bennett, CP
    Vize, CJ
    Desai, SP
    Black, GCM
    Patel, N
    Teimory, M
    Markham, AF
    Inglehearn, CF
    Churchill, AJ
    HUMAN MOLECULAR GENETICS, 2001, 10 (13) : 1369 - 1378
  • [10] Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations
    Alessia Nasca
    Teresa Rizza
    Mara Doimo
    Andrea Legati
    Andrea Ciolfi
    Daria Diodato
    Cristina Calderan
    Gianfranco Carrara
    Eleonora Lamantea
    Chiara Aiello
    Michela Di Nottia
    Marcello Niceta
    Costanza Lamperti
    Anna Ardissone
    Stefania Bianchi-Marzoli
    Giancarlo Iarossi
    Enrico Bertini
    Isabella Moroni
    Marco Tartaglia
    Leonardo Salviati
    Rosalba Carrozzo
    Daniele Ghezzi
    Orphanet Journal of Rare Diseases, 12